Antibody |
gene symbol |
symbol status |
gene name |
UniGene cluster Id |
RefSeq (mRNA) |
RefSeq (protein) |
category |
Entrez Gene Id |
|
A12M1 |
Entry withdrawn |
entry withdrawn |
-
|
-
|
-
|
-
|
-
|
|
A12M2 |
Entry withdrawn |
entry withdrawn |
-
|
-
|
-
|
-
|
-
|
|
A12M3 |
Entry withdrawn |
entry withdrawn |
-
|
-
|
-
|
-
|
-
|
|
A12M4 |
Entry withdrawn |
entry withdrawn |
-
|
-
|
-
|
-
|
-
|
|
ABCB1 |
Approved |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
Hs.21330
|
NM_000927
|
NP_000918
|
Reviewed
|
5243
|
|
ABL1 |
Approved |
v-abl Abelson murine leukemia viral oncogene homolog 1 |
Hs.446504
|
NM_005157 NM_007313
|
NP_005148 NP_009297
|
Reviewed Reviewed
|
25
|
|
ABR |
Approved |
active BCR-related gene |
Hs.434004
|
NM_021962 NM_001092
|
NP_068781 NP_001083
|
Reviewed Reviewed
|
29
|
|
ACHE |
Approved |
acetylcholinesterase (YT blood group) |
Hs.154495
|
NM_015831 NM_000665
|
NP_056646 NP_000656
|
Reviewed Reviewed
|
43
|
|
ACTA1 |
Approved |
actin, alpha 1, skeletal muscle |
Hs.1288 Hs.426930 Hs.118127 Hs.208641 Hs.14376
|
NM_001614 NM_001101 NM_001100 NM_005159 NM_001613
|
NP_001605 NP_001092 NP_001091 NP_005150 NP_001604
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
58
|
|
ACTA2 |
Approved |
actin, alpha 2, smooth muscle, aorta |
Hs.208641 Hs.426930 Hs.14376 Hs.1288 Hs.118127
|
NM_001614 NM_001101 NM_001613 NM_001100 NM_005159
|
NP_001605 NP_001092 NP_001604 NP_001091 NP_005150
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
59
|
|
ACTB |
Approved |
actin, beta |
Hs.1288 Hs.118127 Hs.208641 Hs.14376 Hs.426930
|
NM_001613 NM_001101 NM_001100 NM_001614 NM_005159
|
NP_001604 NP_001092 NP_001091 NP_001605 NP_005150
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
60
|
|
ACTC |
Approved |
actin, alpha, cardiac muscle |
Hs.14376 Hs.426930 Hs.1288 Hs.118127 Hs.208641
|
NM_001614 NM_001100 NM_001613 NM_005159 NM_001101
|
NP_001605 NP_001091 NP_001604 NP_005150 NP_001092
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
70
|
|
ACTG1 |
Approved |
actin, gamma 1 |
Hs.14376 Hs.426930 Hs.208641 Hs.1288 Hs.118127
|
NM_001101 NM_001614 NM_001100 NM_005159 NM_001613
|
NP_001092 NP_001605 NP_001091 NP_005150 NP_001604
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
71
|
|
ACTN1 |
Approved |
actinin, alpha 1 |
Hs.119000
|
NM_001102
|
NP_001093
|
Reviewed
|
87
|
|
ACTR3 |
Approved |
ARP3 actin-related protein 3 homolog (yeast) |
Hs.433512
|
NM_005721
|
NP_005712
|
Reviewed
|
10096
|
|
ACVR2 |
Approved |
activin A receptor, type II |
Hs.389846
|
NM_001616
|
NP_001607
|
Reviewed
|
92
|
|
ADNP |
Approved |
activity-dependent neuroprotector |
Hs.448540
|
NM_181442 NM_015339
|
NP_852107 NP_056154
|
Reviewed Reviewed
|
23394
|
|
ADPRT |
Approved |
ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase) |
Hs.177766
|
NM_001618
|
NP_001609
|
Reviewed
|
142
|
|
AKAP1 |
Approved |
A kinase (PRKA) anchor protein 1 |
Hs.78921
|
NM_139275 NM_003488
|
NP_644804 NP_003479
|
Reviewed Reviewed
|
8165
|
|
AKAP11 |
Approved |
A kinase (PRKA) anchor protein 11 |
Hs.414995
|
NM_144490 NM_016248
|
NP_652761 NP_057332
|
Reviewed Reviewed
|
11215
|
|
AKAP2 |
Approved |
A kinase (PRKA) anchor protein 2 |
Hs.42322
|
NM_147150 NM_007203
|
NP_671492 NP_009134
|
Reviewed Reviewed
|
11217
|
|
AKAP5 |
Approved |
A kinase (PRKA) anchor protein 5 |
Hs.48714
|
NM_004857
|
NP_004848
|
Reviewed
|
9495
|
|
AKAP8 |
Approved |
A kinase (PRKA) anchor protein 8 |
Hs.25059
|
NM_005858
|
NP_005849
|
Reviewed
|
10270
|
|
AKT1 |
Approved |
v-akt murine thymoma viral oncogene homolog 1 |
Hs.368861
|
NM_005163
|
NP_005154
|
Reviewed
|
207
|
|
ALDH1A1 |
Approved |
aldehyde dehydrogenase 1 family, member A1 |
Hs.76392
|
NM_000689
|
NP_000680
|
Reviewed
|
216
|
|
AMACR |
Approved |
alpha-methylacyl-CoA racemase |
Hs.49598
|
NM_014324 NM_203382
|
NP_055139 NP_976316
|
Validated Validated
|
23600
|
|
AMPH |
Approved |
amphiphysin (Stiff-Man syndrome with breast cancer 128kDa autoantigen) |
Hs.173034
|
NM_139316 NM_001635
|
NP_647477 NP_001626
|
Reviewed Reviewed
|
273
|
|
ANPEP |
Approved |
alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) |
Hs.1239
|
NM_001150
|
NP_001141
|
Reviewed
|
290
|
|
ANXA1 |
Approved |
annexin A1 |
Hs.287558
|
NM_000700
|
NP_000691
|
Reviewed
|
301
|
|
ANXA11 |
Approved |
annexin A11 |
Hs.75510
|
NM_145868 NM_145869 NM_001157
|
NP_665875 NP_665876 NP_001148
|
Reviewed Reviewed Reviewed
|
311
|
|
ANXA2 |
Approved |
annexin A2 |
Hs.462864
|
NM_004039
|
NP_004030
|
Reviewed
|
302
|
|
ANXA4 |
Approved |
annexin A4 |
Hs.422986
|
NM_001153
|
NP_001144
|
Reviewed
|
307
|
|
ANXA6 |
Approved |
annexin A6 |
Hs.412117
|
NM_001155 NM_004033
|
NP_001146 NP_004024
|
Reviewed Reviewed
|
309
|
|
ANXA7 |
Approved |
annexin A7 |
Hs.386741
|
NM_004034 NM_001156
|
NP_004025 NP_001147
|
Reviewed Reviewed
|
310
|
|
AOX1 |
Approved |
aldehyde oxidase 1 |
Hs.406238
|
NM_001159
|
NP_001150
|
Reviewed
|
316
|
|
AP1G1 |
Approved |
adaptor-related protein complex 1, gamma 1 subunit |
Hs.5344
|
NM_001128
|
NP_001119
|
Reviewed
|
164
|
|
AP2A1 |
Approved |
adaptor-related protein complex 2, alpha 1 subunit |
Hs.296426
|
NM_014203 NM_130787
|
NP_055018 NP_570603
|
Reviewed Reviewed
|
160
|
|
AP2B1 |
Approved |
adaptor-related protein complex 2, beta 1 subunit |
Hs.370123
|
NM_001282
|
NP_001273
|
Reviewed
|
163
|
|
AP2M1 |
Approved |
adaptor-related protein complex 2, mu 1 subunit |
Hs.433892
|
NM_004068
|
NP_004059
|
Reviewed
|
1173
|
|
AP3D1 |
Approved |
adaptor-related protein complex 3, delta 1 subunit |
Hs.512815
|
NM_003938
|
NP_003929
|
Validated
|
8943
|
|
AP4E1 |
Approved |
adaptor-related protein complex 4, epsilon 1 subunit |
Hs.413366
|
NM_007347
|
NP_031373
|
Validated
|
23431
|
|
APAF1 |
Approved |
apoptotic protease activating factor |
Hs.373575
|
NM_181861 NM_181868 NM_013229 NM_181869 NM_001160
|
NP_863651 NP_863658 NP_037361 NP_863659 NP_001151
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
317
|
|
APBA1 |
Approved |
amyloid beta (A4) precursor protein-binding, family A, member 1 (X11) |
Hs.4880
|
NM_001163
|
NP_001154
|
Reviewed
|
320
|
|
APBA2 |
Approved |
amyloid beta (A4) precursor protein-binding, family A, member 2 (X11-like) |
Hs.26468
|
NM_005503
|
NP_005494
|
Reviewed
|
321
|
|
APC |
Approved |
adenomatosis polyposis coli |
Hs.75081
|
NM_000038
|
NP_000029
|
Reviewed
|
324
|
|
APEX1 |
Approved |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
Hs.73722
|
NM_080648 NM_001641 NM_080649
|
NP_542379 NP_001632 NP_542380
|
Reviewed Reviewed Reviewed
|
328
|
|
APOE |
Approved |
apolipoprotein E |
Hs.110675
|
NM_000041
|
NP_000032
|
Reviewed
|
348
|
|
APPBP1 |
Approved |
amyloid beta precursor protein binding protein 1, 59kDa |
Hs.418162
|
NM_003905
|
NP_003896
|
Reviewed
|
8883
|
|
AR |
Approved |
androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) |
Hs.99915
|
NM_000044
|
NP_000035
|
Reviewed
|
367
|
|
ARF6 |
Approved |
ADP-ribosylation factor 6 |
Hs.89474
|
NM_001663
|
NP_001654
|
Reviewed
|
382
|
|
ARHGAP1 |
Approved |
Rho GTPase activating protein 1 |
Hs.138860
|
NM_004308
|
NP_004299
|
Provisional
|
392
|
|
ARNT |
Approved |
aryl hydrocarbon receptor nuclear translocator |
Hs.131494
|
NM_178427 NM_001668 NM_178426
|
NP_848514 NP_001659 NP_848513
|
Reviewed Reviewed Reviewed
|
405
|
|
ARRB1 |
Approved |
arrestin, beta 1 |
Hs.112278
|
NM_020251 NM_004041
|
NP_064647 NP_004032
|
Reviewed Reviewed
|
408
|
|
ASS |
Approved |
argininosuccinate synthetase |
Hs.160786
|
NM_054012 NM_000050
|
NP_446464 NP_000041
|
Reviewed Reviewed
|
445
|
|
ATM |
Approved |
ataxia telangiectasia mutated (includes complementation groups A, C and D) |
Hs.526394
|
NM_000051 NM_138292 NM_138293
|
NP_000042 NP_612149 NP_612150
|
Reviewed Reviewed Reviewed
|
472
|
|
ATP1B3 |
Approved |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
Hs.76941
|
NM_001679
|
NP_001670
|
Provisional
|
483
|
|
ATP5A1 |
Approved |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle |
Hs.298280
|
NM_004046
|
NP_004037
|
Provisional
|
498
|
|
ATP5B |
Approved |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
Hs.406510
|
NM_001686
|
NP_001677
|
Provisional
|
506
|
|
ATRN |
Approved |
attractin |
Hs.373838
|
NM_139321 NM_139322 NM_012070
|
NP_647537 NP_647538 NP_036202
|
Reviewed Reviewed Reviewed
|
8455
|
|
AURKB |
Approved |
aurora kinase B |
Hs.442658
|
NM_004217
|
NP_004208
|
Provisional
|
9212
|
|
AVEN |
Approved |
apoptosis, caspase activation inhibitor |
Hs.63168
|
NM_020371
|
NP_065104
|
Provisional
|
57099
|
|
AZGP1 |
Approved |
alpha-2-glycoprotein 1, zinc |
Hs.512643
|
NM_001185
|
NP_001176
|
Validated
|
563
|
|
BAD |
Approved |
BCL2-antagonist of cell death |
Hs.76366
|
NM_004322 NM_032989
|
NP_004313 NP_116784
|
Reviewed Reviewed
|
572
|
|
BAG1 |
Approved |
BCL2-associated athanogene |
Hs.377484
|
NM_004323
|
NP_004314
|
Reviewed
|
573
|
|
BAX |
Approved |
BCL2-associated X protein |
Hs.159428
|
NM_138762 NM_004324 NM_138764 NM_138761 NM_138763 NM_138765
|
NP_620117 NP_004315 NP_620119 NP_620116 NP_620118 NP_620120
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
581
|
|
BCAR1 |
Approved |
breast cancer anti-estrogen resistance 1 |
Hs.273219
|
NM_014567
|
NP_055382
|
Validated
|
9564
|
|
BCL2 |
Approved |
B-cell CLL/lymphoma 2 |
Hs.501181 Hs.79241
|
NM_000633 NM_000657
|
NP_000624 NP_000648
|
Reviewed Reviewed
|
596
|
|
BCLAF1 |
Approved |
BCL2-associated transcription factor 1 |
Hs.80338
|
-
|
-
|
-
|
9774
|
|
BDKRB2 |
Approved |
bradykinin receptor B2 |
Hs.250882
|
NM_000623
|
NP_000614
|
Reviewed
|
624
|
|
BECN1 |
Approved |
beclin 1 (coiled-coil, myosin-like BCL2 interacting protein) |
Hs.12272
|
NM_003766
|
NP_003757
|
Provisional
|
8678
|
|
BIN1 |
Approved |
bridging integrator 1 |
Hs.193163
|
NM_139346 NM_139344 NM_139349 NM_139348 NM_139343 NM_139350 NM_139345 NM_139351 NM_139347 NM_004305
|
NP_647596 NP_647594 NP_647599 NP_647598 NP_647593 NP_647600 NP_647595 NP_647601 NP_647597 NP_004296
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
274
|
|
BIRC4 |
Approved |
baculoviral IAP repeat-containing 4 |
Hs.356076
|
NM_001167
|
NP_001158
|
Reviewed
|
331
|
|
BIRC6 |
Approved |
baculoviral IAP repeat-containing 6 (apollon) |
Hs.360026
|
NM_016252
|
NP_057336
|
Provisional
|
57448
|
|
BMPR2 |
Approved |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
Hs.53250
|
NM_033346 NM_001204
|
NP_203132 NP_001195
|
Reviewed Reviewed
|
659
|
|
BMX |
Approved |
BMX non-receptor tyrosine kinase |
Hs.27372
|
NM_203281 NM_001721
|
NP_975010 NP_001712
|
Validated Validated
|
660
|
|
BNIP1 |
Approved |
BCL2/adenovirus E1B 19kDa interacting protein 1 |
Hs.145726
|
NM_013979 NM_001205 NM_013980 NM_013978
|
NP_053582 NP_001196 NP_053583 NP_053581
|
Reviewed Reviewed Reviewed Reviewed
|
662
|
|
BPNT1 |
Approved |
3'(2'), 5'-bisphosphate nucleotidase 1 |
Hs.271752
|
NM_006085
|
NP_006076
|
Validated
|
10380
|
|
BRCA1 |
Approved |
breast cancer 1, early onset |
Hs.194143
|
NM_007304 NM_007300 NM_007296 NM_007305 NM_007295 NM_007306 NM_007301 NM_007302 NM_007294 NM_007298 NM_007303 NM_007299 NM_007297
|
NP_009235 NP_009231 NP_009227 NP_009236 NP_009226 NP_009237 NP_009232 NP_009233 NP_009225 NP_009229 NP_009234 NP_009230 NP_009228
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
672
|
|
BTK |
Approved |
Bruton agammaglobulinemia tyrosine kinase |
Hs.159494
|
NM_000061
|
NP_000052
|
Reviewed
|
695
|
|
BUB1B |
Approved |
BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) |
Hs.36708
|
NM_001211
|
NP_001202
|
Provisional
|
701
|
|
BUB3 |
Approved |
BUB3 budding uninhibited by benzimidazoles 3 homolog (yeast) |
Hs.418533
|
NM_004725
|
NP_004716
|
Provisional
|
9184
|
|
C1QBP |
Approved |
complement component 1, q subcomponent binding protein |
Hs.78614
|
NM_001212
|
NP_001203
|
Reviewed
|
708
|
|
CALD1 |
Approved |
caldesmon 1 |
Hs.443811
|
NM_033139 NM_004342 NM_033138 NM_033140 NM_033157
|
NP_149130 NP_004333 NP_149129 NP_149131 NP_149347
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
800
|
|
CALM1 |
Approved |
calmodulin 1 (phosphorylase kinase, delta) |
Hs.282410
|
NM_006888
|
NP_008819
|
Provisional
|
801
|
|
CALR |
Approved |
calreticulin |
Hs.353170
|
NM_004343
|
NP_004334
|
Reviewed
|
811
|
|
CAMK2A |
Approved |
calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha |
Hs.143535
|
NM_015981 NM_171825
|
NP_057065 NP_741960
|
Reviewed Reviewed
|
815
|
|
CAMK4 |
Approved |
calcium/calmodulin-dependent protein kinase IV |
Hs.440638
|
NM_001744
|
NP_001735
|
Reviewed
|
814
|
|
CANX |
Approved |
calnexin |
Hs.155560
|
NM_001746
|
NP_001737
|
Provisional
|
821
|
|
CAPZA1 |
Approved |
capping protein (actin filament) muscle Z-line, alpha 1 |
Hs.309415 Hs.369579
|
NM_006136 NM_006135
|
NP_006127 NP_006126
|
Reviewed Reviewed
|
829
|
|
CAPZA2 |
Approved |
capping protein (actin filament) muscle Z-line, alpha 2 |
Hs.309415 Hs.369579
|
NM_006135 NM_006136
|
NP_006126 NP_006127
|
Reviewed Reviewed
|
830
|
|
CASK |
Approved |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
Hs.288196
|
NM_003688
|
NP_003679
|
Provisional
|
8573
|
|
CASP14 |
Approved |
caspase 14, apoptosis-related cysteine protease |
Hs.248226
|
NM_012114
|
NP_036246
|
Reviewed
|
23581
|
|
CASP2 |
Approved |
caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) |
Hs.433103
|
NM_032983 NM_001224 NM_032984 NM_032982
|
NP_116765 NP_001215 NP_116766 NP_116764
|
Reviewed Reviewed Reviewed Reviewed
|
835
|
|
CASP3 |
Approved |
caspase 3, apoptosis-related cysteine protease |
Hs.141125
|
NM_004346 NM_032991
|
NP_004337 NP_116786
|
Reviewed Reviewed
|
836
|
|
CASP6 |
Approved |
caspase 6, apoptosis-related cysteine protease |
Hs.3280
|
NM_001226 NM_032992
|
NP_001217 NP_116787
|
Reviewed Reviewed
|
839
|
|
CASP7 |
Approved |
caspase 7, apoptosis-related cysteine protease |
Hs.9216
|
NM_001227 NM_033339 NM_033340 NM_033338
|
NP_001218 NP_203125 NP_203126 NP_203124
|
Reviewed Reviewed Reviewed Reviewed
|
840
|
|
CASP8 |
Approved |
caspase 8, apoptosis-related cysteine protease |
Hs.243491
|
NM_033357 NM_033355 NM_001228 NM_033356 NM_033358
|
NP_203521 NP_203519 NP_001219 NP_203520 NP_203522
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
841
|
|
CASP9 |
Approved |
caspase 9, apoptosis-related cysteine protease |
Hs.329502
|
NM_001229 NM_032996
|
NP_001220 NP_127463
|
Reviewed Reviewed
|
842
|
|
CAV1 |
Approved |
caveolin 1, caveolae protein, 22kDa |
Hs.74034
|
NM_001753
|
NP_001744
|
Reviewed
|
857
|
|
CBL |
Approved |
Cas-Br-M (murine) ecotropic retroviral transforming sequence |
Hs.41324
|
NM_005188
|
NP_005179
|
Reviewed
|
867
|
|
CCNA2 |
Approved |
cyclin A2 |
Hs.85137
|
NM_001237
|
NP_001228
|
Reviewed
|
890
|
|
CCNB1 |
Approved |
cyclin B1 |
Hs.23960
|
NM_031966
|
NP_114172
|
Reviewed
|
891
|
|
CCND1 |
Approved |
cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
Hs.371468
|
NM_053056 NM_001758
|
NP_444284 NP_001749
|
Reviewed Secondary
|
595
|
|
CCND2 |
Approved |
cyclin D2 |
Hs.376071
|
NM_001759
|
NP_001750
|
Reviewed
|
894
|
|
CCND3 |
Approved |
cyclin D3 |
Hs.83173
|
NM_001760
|
NP_001751
|
Reviewed
|
896
|
|
CCNE1 |
Approved |
cyclin E1 |
Hs.244723
|
NM_001238 NM_057182
|
NP_001229 NP_476530
|
Reviewed Reviewed
|
898
|
|
CD37 |
Approved |
CD37 antigen |
Hs.166556
|
NM_001774
|
NP_001765
|
Reviewed
|
951
|
|
CD38 |
Approved |
CD38 antigen (p45) |
Hs.174944
|
NM_001775
|
NP_001766
|
Validated
|
952
|
|
CD44 |
Approved |
CD44 antigen (homing function and Indian blood group system) |
Hs.306278
|
NM_000610
|
NP_000601
|
Provisional
|
960
|
|
CD74 |
Approved |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
Hs.446471
|
NM_004355
|
NP_004346
|
Provisional
|
972
|
|
CD79A |
Approved |
CD79A antigen (immunoglobulin-associated alpha) |
Hs.79630
|
NM_001783 NM_021601
|
NP_001774 NP_067612
|
Reviewed Reviewed
|
973
|
|
CDC2 |
Approved |
cell division cycle 2, G1 to S and G2 to M |
Hs.334562
|
NM_001786 NM_033379
|
NP_001777 NP_203698
|
Reviewed Reviewed
|
983
|
|
CDC20 |
Approved |
CDC20 cell division cycle 20 homolog (S. cerevisiae) |
Hs.82906
|
NM_001255
|
NP_001246
|
Reviewed
|
991
|
|
CDC25B |
Approved |
cell division cycle 25B |
Hs.153752
|
NM_021874 NM_021872 NM_004358 NM_021873
|
NP_068660 NP_068658 NP_004349 NP_068659
|
Reviewed Reviewed Reviewed Reviewed
|
994
|
|
CDC25C |
Approved |
cell division cycle 25C |
Hs.656
|
NM_001790 NM_022809
|
NP_001781 NP_073720
|
Reviewed Reviewed
|
995
|
|
CDC27 |
Approved |
cell division cycle 27 |
Hs.406631
|
NM_001256
|
NP_001247
|
Reviewed
|
996
|
|
CDC34 |
Approved |
cell division cycle 34 |
Hs.423615
|
NM_004359
|
NP_004350
|
Reviewed
|
997
|
|
CDC37 |
Approved |
CDC37 cell division cycle 37 homolog (S. cerevisiae) |
Hs.160958
|
NM_007065
|
NP_008996
|
Reviewed
|
11140
|
|
CDC42 |
Approved |
cell division cycle 42 (GTP binding protein, 25kDa) |
Hs.355832
|
NM_001791 NM_044472
|
NP_001782 NP_426359
|
Reviewed Reviewed
|
998
|
|
CDC5L |
Approved |
CDC5 cell division cycle 5-like (S. pombe) |
Hs.443753
|
NM_001253
|
NP_001244
|
Reviewed
|
988
|
|
CDC6 |
Approved |
CDC6 cell division cycle 6 homolog (S. cerevisiae) |
Hs.405958
|
NM_001254
|
NP_001245
|
Reviewed
|
990
|
|
CDH1 |
Approved |
cadherin 1, type 1, E-cadherin (epithelial) |
Hs.194657
|
NM_004360
|
NP_004351
|
Reviewed
|
999
|
|
CDH15 |
Approved |
cadherin 15, M-cadherin (myotubule) |
Hs.148090
|
NM_004933
|
NP_004924
|
Reviewed
|
1013
|
|
CDH2 |
Approved |
cadherin 2, type 1, N-cadherin (neuronal) |
Hs.334131
|
NM_001792
|
NP_001783
|
Reviewed
|
1000
|
|
CDH3 |
Approved |
cadherin 3, type 1, P-cadherin (placental) |
Hs.191842
|
NM_001793
|
NP_001784
|
Reviewed
|
1001
|
|
CDH4 |
Approved |
cadherin 4, type 1, R-cadherin (retinal) |
Hs.376792
|
NM_001794
|
NP_001785
|
Reviewed
|
1002
|
|
CDH5 |
Approved |
cadherin 5, type 2, VE-cadherin (vascular epithelium) |
Hs.76206
|
NM_001795
|
NP_001786
|
Reviewed
|
1003
|
|
CDK2 |
Approved |
cyclin-dependent kinase 2 |
Hs.19192
|
NM_001798 NM_052827
|
NP_001789 NP_439892
|
Reviewed Reviewed
|
1017
|
|
CDK4 |
Approved |
cyclin-dependent kinase 4 |
Hs.95577
|
NM_000075 NM_032913
|
NP_000066 NP_116302
|
Reviewed Secondary
|
1019
|
|
CDK5 |
Approved |
cyclin-dependent kinase 5 |
Hs.166071
|
NM_004935
|
NP_004926
|
Validated
|
1020
|
|
CDK6 |
Approved |
cyclin-dependent kinase 6 |
Hs.38481 Hs.388761
|
NM_001259
|
NP_001250
|
Reviewed
|
1021
|
|
CDK7 |
Approved |
cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase) |
Hs.184298
|
NM_001799
|
NP_001790
|
Reviewed
|
1022
|
|
CDKN1A |
Approved |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
Hs.370771
|
NM_000389 NM_078467
|
NP_000380 NP_510867
|
Reviewed Reviewed
|
1026
|
|
CDKN1B |
Approved |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
Hs.238990
|
NM_004064
|
NP_004055
|
Reviewed
|
1027
|
|
CDKN1C |
Approved |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
Hs.106070
|
NM_000076
|
NP_000067
|
Reviewed
|
1028
|
|
CDKN2A |
Approved |
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
Hs.421349
|
NM_000077 NM_058195 NM_058197 NM_058196
|
NP_000068 NP_478102 NP_478104 NP_478103
|
Reviewed Reviewed Reviewed Reviewed
|
1029
|
|
CDKN2B |
Approved |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
Hs.72901
|
NM_004936 NM_078487
|
NP_004927 NP_511042
|
Reviewed Reviewed
|
1030
|
|
CDKN3 |
Approved |
cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) |
Hs.84113
|
NM_005192
|
NP_005183
|
Reviewed
|
1033
|
|
CEACAM5 |
Approved |
carcinoembryonic antigen-related cell adhesion molecule 5 |
Hs.220529
|
NM_004363
|
NP_004354
|
Provisional
|
1048
|
|
CENTA1 |
Approved |
centaurin, alpha 1 |
Hs.135183
|
NM_006869
|
NP_006860
|
Provisional
|
11033
|
|
CENTB2 |
Approved |
centaurin, beta 2 |
Hs.410715
|
NM_012287
|
NP_036419
|
Provisional
|
23527
|
|
CGB5 |
Approved |
chorionic gonadotropin, beta polypeptide 5 |
Hs.172944
|
NM_033043
|
NP_149032
|
Reviewed
|
93659
|
|
CHAF1A |
Approved |
chromatin assembly factor 1, subunit A (p150) |
Hs.79018
|
NM_005483
|
NP_005474
|
Provisional
|
10036
|
|
CHC1 |
Approved |
chromosome condensation 1 |
Hs.196769
|
NM_001269
|
NP_001260
|
Provisional
|
1104
|
|
CHD3 |
Approved |
chromodomain helicase DNA binding protein 3 |
Hs.25601
|
-
|
-
|
-
|
1107
|
|
CHEK1 |
Approved |
CHK1 checkpoint homolog (S. pombe) |
Hs.24529
|
NM_001274
|
NP_001265
|
Provisional
|
1111
|
|
CHEK2 |
Approved |
CHK2 checkpoint homolog (S. pombe) |
Hs.146329
|
NM_145862 NM_007194
|
NP_665861 NP_009125
|
Reviewed Reviewed
|
11200
|
|
CHGA |
Approved |
chromogranin A (parathyroid secretory protein 1) |
Hs.124411
|
NM_001275
|
NP_001266
|
Reviewed
|
1113
|
|
CHGB |
Approved |
chromogranin B (secretogranin 1) |
Hs.2281
|
NM_001819
|
NP_001810
|
Reviewed
|
1114
|
|
CHRNB1 |
Approved |
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
Hs.330386
|
NM_000747
|
NP_000738
|
Reviewed
|
1140
|
|
CIT |
Approved |
citron (rho-interacting, serine/threonine kinase 21) |
Hs.528307
|
NM_007174
|
NP_009105
|
Validated
|
11113
|
|
CLTA |
Approved |
clathrin, light polypeptide (Lca) |
Hs.380749 Hs.207052
|
NM_001834 NM_007097 NM_007096 NM_001833
|
NP_001825 NP_009028 NP_009027 NP_001824
|
Reviewed Reviewed Reviewed Reviewed
|
1211
|
|
CLTB |
Approved |
clathrin, light polypeptide (Lcb) |
Hs.380749 Hs.207052
|
NM_001833 NM_007097 NM_007096 NM_001834
|
NP_001824 NP_009028 NP_009027 NP_001825
|
Reviewed Reviewed Reviewed Reviewed
|
1212
|
|
CLTC |
Approved |
clathrin, heavy polypeptide (Hc) |
Hs.187416
|
NM_004859
|
NP_004850
|
Reviewed
|
1213
|
|
CNN1 |
Approved |
calponin 1, basic, smooth muscle |
Hs.21223
|
NM_001299
|
NP_001290
|
Provisional
|
1264
|
|
CNP |
Approved |
2',3'-cyclic nucleotide 3' phosphodiesterase |
Hs.443836
|
NM_033133
|
NP_149124
|
Validated
|
1267
|
|
CNTN1 |
Approved |
contactin 1 |
Hs.143434
|
NM_175038 NM_001843
|
NP_778203 NP_001834
|
Reviewed Reviewed
|
1272
|
|
COIL |
Approved |
coilin |
Hs.966
|
NM_004645
|
NP_004636
|
Provisional
|
8161
|
|
COL7A1 |
Approved |
collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) |
Hs.1640
|
NM_000094
|
NP_000085
|
Reviewed
|
1294
|
|
COPS5 |
Approved |
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis) |
Hs.446492
|
NM_006837
|
NP_006828
|
Reviewed
|
10987
|
|
CP |
Approved |
ceruloplasmin (ferroxidase) |
Hs.282557
|
NM_000096
|
NP_000087
|
Reviewed
|
1356
|
|
CPE |
Approved |
carboxypeptidase E |
Hs.75360
|
NM_001873
|
NP_001864
|
Reviewed
|
1363
|
|
CPLX2 |
Approved |
complexin 2 |
Hs.193235
|
NM_006650
|
NP_006641
|
Reviewed
|
10814
|
|
CRIP1 |
Approved |
cysteine-rich protein 1 (intestinal) |
Hs.70327
|
NM_001311
|
NP_001302
|
Provisional
|
1396
|
|
CRK |
Approved |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
Hs.511822
|
NM_005206 NM_016823
|
NP_005197 NP_058431
|
Reviewed Reviewed
|
1398
|
|
CSE1L |
Approved |
CSE1 chromosome segregation 1-like (yeast) |
Hs.90073
|
NM_001316 NM_177436
|
NP_001307 NP_803185
|
Reviewed Reviewed
|
1434
|
|
CSK |
Approved |
c-src tyrosine kinase |
Hs.77793
|
NM_004383
|
NP_004374
|
Provisional
|
1445
|
|
CSN2 |
Approved |
casein beta |
Hs.2242
|
NM_001891
|
NP_001882
|
Provisional
|
1447
|
|
CSNK1E |
Approved |
casein kinase 1, epsilon |
Hs.355669
|
NM_152221 NM_001894
|
NP_689407 NP_001885
|
Reviewed Reviewed
|
1454
|
|
CSNK2A1 |
Approved |
casein kinase 2, alpha 1 polypeptide |
Hs.446484
|
NM_177559 NM_177560 NM_001895
|
NP_808227 NP_808228 NP_001886
|
Reviewed Reviewed Reviewed
|
1457
|
|
CSRP1 |
Approved |
cysteine and glycine-rich protein 1 |
Hs.108080 Hs.519046
|
NM_004078
|
NP_004069
|
Reviewed
|
1465
|
|
CTBP1 |
Approved |
C-terminal binding protein 1 |
Hs.196083
|
NM_001328
|
NP_001319
|
Reviewed
|
1487
|
|
CTBP2 |
Approved |
C-terminal binding protein 2 |
Hs.171391
|
NM_022802 NM_001329
|
NP_073713 NP_001320
|
Reviewed Reviewed
|
1488
|
|
CTCF |
Approved |
CCCTC-binding factor (zinc finger protein) |
Hs.411515
|
NM_006565
|
NP_006556
|
Provisional
|
10664
|
|
CTNNA1 |
Approved |
catenin (cadherin-associated protein), alpha 1, 102kDa |
Hs.254321
|
NM_001903
|
NP_001894
|
Provisional
|
1495
|
|
CTNNB1 |
Approved |
catenin (cadherin-associated protein), beta 1, 88kDa |
Hs.410086
|
NM_001904
|
NP_001895
|
Provisional
|
1499
|
|
CTNND1 |
Approved |
catenin (cadherin-associated protein), delta 1 |
Hs.166011
|
NM_001331
|
NP_001322
|
Provisional
|
1500
|
|
CTNNG |
Approved |
catenin (cadherin-associated protein), gamma 80kDa |
-
|
-
|
-
|
-
|
1502
|
|
CTSD |
Approved |
cathepsin D (lysosomal aspartyl protease) |
Hs.343475
|
NM_001909
|
NP_001900
|
Reviewed
|
1509
|
|
CTSL |
Approved |
cathepsin L |
Hs.418123
|
NM_001912 NM_145918
|
NP_001903 NP_666023
|
Reviewed Reviewed
|
1514
|
|
CUL1 |
Approved |
cullin 1 |
Hs.348153
|
NM_003592
|
NP_003583
|
Validated
|
8454
|
|
CUL2 |
Approved |
cullin 2 |
Hs.82919
|
NM_003591
|
NP_003582
|
Provisional
|
8453
|
|
CUL3 |
Approved |
cullin 3 |
Hs.78946
|
-
|
-
|
-
|
8452
|
|
CYCS |
Approved |
cytochrome c, somatic |
Hs.437060
|
NM_018947
|
NP_061820
|
Reviewed
|
54205
|
|
CYLN2 |
Approved |
cytoplasmic linker 2 |
Hs.104717
|
NM_032421 NM_003388 NM_032719
|
NP_115797 NP_003379 NP_116108
|
Reviewed Reviewed Secondary
|
7461
|
|
DAG1 |
Approved |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
Hs.76111
|
NM_004393
|
NP_004384
|
Reviewed
|
1605
|
|
DAP3 |
Approved |
death associated protein 3 |
Hs.270920
|
NM_033657 NM_004632
|
NP_387506 NP_004623
|
Reviewed Reviewed
|
7818
|
|
DAPK1 |
Approved |
death-associated protein kinase 1 |
Hs.244318
|
NM_004938
|
NP_004929
|
Reviewed
|
1612
|
|
DCTN2 |
Approved |
dynactin 2 (p50) |
Hs.289123
|
NM_006400
|
NP_006391
|
Reviewed
|
10540
|
|
DDEF1 |
Approved |
development and differentiation enhancing factor 1 |
Hs.386779
|
-
|
-
|
-
|
50807
|
|
DDX1 |
Approved |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 |
Hs.440599
|
NM_004939
|
NP_004930
|
Reviewed
|
1653
|
|
DDX20 |
Approved |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
Hs.65412
|
NM_007204
|
NP_009135
|
Reviewed
|
11218
|
|
DEK |
Approved |
DEK oncogene (DNA binding) |
Hs.110713
|
NM_003472
|
NP_003463
|
Provisional
|
7913
|
|
DFFA |
Approved |
DNA fragmentation factor, 45kDa, alpha polypeptide |
Hs.484782
|
NM_004401
|
NP_004392
|
Reviewed
|
1676
|
|
DGKI |
Approved |
diacylglycerol kinase, iota |
Hs.242947
|
NM_004717
|
NP_004708
|
Reviewed
|
9162
|
|
DGKQ |
Approved |
diacylglycerol kinase, theta 110kDa |
Hs.99932
|
NM_001347
|
NP_001338
|
Reviewed
|
1609
|
|
DHX16 |
Approved |
DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
Hs.12797
|
NM_003587
|
NP_003578
|
Reviewed
|
8449
|
|
DLC1 |
Approved |
deleted in liver cancer 1 |
Hs.8700
|
NM_006094 NM_024767 NM_182643
|
NP_006085 NP_079043 NP_872584
|
Reviewed Reviewed Reviewed
|
10395
|
|
DLG1 |
Approved |
discs, large homolog 1 (Drosophila) |
Hs.389893
|
NM_004087
|
NP_004078
|
Provisional
|
1739
|
|
DLG4 |
Approved |
discs, large homolog 4 (Drosophila) |
Hs.23731
|
NM_001365
|
NP_001356
|
Reviewed
|
1742
|
|
DMPK |
Approved |
dystrophia myotonica-protein kinase |
Hs.898 Hs.275924 Hs.502170
|
NM_004409 XM_371180
|
NP_004400 XP_371180
|
Provisional Model, mRNA evidence
|
1760
|
|
DMWD |
Approved |
dystrophia myotonica-containing WD repeat motif |
Hs.502170 Hs.275924 Hs.898
|
XM_371180 NM_004409
|
XP_371180 NP_004400
|
Model, mRNA evidence Provisional
|
1762
|
|
DNAJA1 |
Approved |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
Hs.388392
|
NM_001539
|
NP_001530
|
Provisional
|
3301
|
|
DNAJB1 |
Approved |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
Hs.82646
|
NM_006145
|
NP_006136
|
Provisional
|
3337
|
|
DNM1 |
Approved |
dynamin 1 |
Hs.436132
|
NM_004408
|
NP_004399
|
Provisional
|
1759
|
|
DNM1L |
Approved |
dynamin 1-like |
Hs.180628
|
NM_012062 NM_012063 NM_005690
|
NP_036192 NP_036193 NP_005681
|
Reviewed Reviewed Reviewed
|
10059
|
|
DNM2 |
Approved |
dynamin 2 |
Hs.432832
|
NM_004945
|
NP_004936
|
Provisional
|
1785
|
|
DOK2 |
Approved |
docking protein 2, 56kDa |
Hs.71215
|
NM_201349 NM_003974
|
NP_958728 NP_003965
|
Reviewed Reviewed
|
9046
|
|
DSG1 |
Approved |
desmoglein 1 |
Hs.2633
|
NM_001942
|
NP_001933
|
Reviewed
|
1828
|
|
DUSP4 |
Approved |
dual specificity phosphatase 4 |
Hs.417962
|
NM_057158 NM_001394
|
NP_476499 NP_001385
|
Reviewed Reviewed
|
1846
|
|
DYRK1A |
Approved |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
Hs.75842
|
NM_101395 NM_130436 NM_130438 NM_001396 NM_130437
|
NP_567824 NP_569120 NP_569122 NP_001387 NP_569121
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
1859
|
|
E2F1 |
Approved |
E2F transcription factor 1 |
Hs.96055
|
NM_005225
|
NP_005216
|
Reviewed
|
1869
|
|
E2F2 |
Approved |
E2F transcription factor 2 |
Hs.231444
|
NM_004091
|
NP_004082
|
Reviewed
|
1870
|
|
E2F4 |
Approved |
E2F transcription factor 4, p107/p130-binding |
Hs.108371
|
NM_001950
|
NP_001941
|
Reviewed
|
1874
|
|
EEA1 |
Approved |
early endosome antigen 1, 162kD |
Hs.2864
|
NM_003566
|
NP_003557
|
Provisional
|
8411
|
|
EGFR |
Approved |
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) |
Hs.77432
|
NM_005228 NM_201284 NM_201283 NM_201282
|
NP_005219 NP_958441 NP_958440 NP_958439
|
Validated Validated Validated Validated
|
1956
|
|
EIF4G1 |
Approved |
eukaryotic translation initiation factor 4 gamma, 1 |
Hs.433750
|
NM_182917 NM_198242 NM_004953 NM_198244 NM_198241
|
NP_886553 NP_937885 NP_004944 NP_937887 NP_937884
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
1981
|
|
EMS1 |
Approved |
ems1 sequence (mammary tumor and squamous cell carcinoma-associated (p80/85 src substrate) |
Hs.301348
|
NM_005231 NM_138565
|
NP_005222 NP_612632
|
Reviewed Reviewed
|
2017
|
|
ENAH |
Approved |
enabled homolog (Drosophila) |
Hs.446693
|
NM_145240 XM_351323 XM_371348 NM_018212
|
NP_660283 XP_351324 XP_371348 NP_060682
|
Secondary Secondary Model, mRNA and EST evidence Provisional
|
55740
|
|
ENO2 |
Approved |
enolase 2, (gamma, neuronal) |
Hs.511915
|
NM_001975
|
NP_001966
|
Reviewed
|
2026
|
|
EP300 |
Approved |
E1A binding protein p300 |
Hs.271730
|
NM_001429
|
NP_001420
|
Reviewed
|
2033
|
|
EPB49 |
Approved |
erythrocyte membrane protein band 4.9 (dematin) |
Hs.274122
|
NM_001978
|
NP_001969
|
Provisional
|
2039
|
|
EPS8 |
Approved |
epidermal growth factor receptor pathway substrate 8 |
Hs.2132
|
NM_004447
|
NP_004438
|
Provisional
|
2059
|
|
ERBB2 |
Approved |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Hs.446352
|
NM_004448
|
NP_004439
|
Provisional
|
2064
|
|
ERBB3 |
Approved |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
Hs.306251
|
NM_001982
|
NP_001973
|
Provisional
|
2065
|
|
ERCC1 |
Approved |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
Hs.435981
|
NM_202001 NM_001983
|
NP_973730 NP_001974
|
Validated Validated
|
2067
|
|
ERCC4 |
Approved |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
Hs.511917
|
NM_005236
|
NP_005227
|
Provisional
|
2072
|
|
ESPN |
Approved |
espin |
Hs.512771
|
NM_031475
|
NP_113663
|
Provisional
|
83715
|
|
ESR1 |
Approved |
estrogen receptor 1 |
Hs.1657
|
NM_000125
|
NP_000116
|
Provisional
|
2099
|
|
F11R |
Approved |
F11 receptor |
Hs.506845
|
NM_016946 NM_144503 NM_144504 NM_144501 NM_144502
|
NP_058642 NP_653086 NP_653087 NP_653084 NP_653085
|
Reviewed Reviewed Reviewed Reviewed Reviewed
|
50848
|
|
F13A1 |
Approved |
coagulation factor XIII, A1 polypeptide |
Hs.80424
|
NM_000129
|
NP_000120
|
Reviewed
|
2162
|
|
FADD |
Approved |
Fas (TNFRSF6)-associated via death domain |
Hs.86131
|
NM_003824
|
NP_003815
|
Reviewed
|
8772
|
|
FBN1 |
Approved |
fibrillin 1 (Marfan syndrome) |
Hs.750
|
NM_000138
|
NP_000129
|
Reviewed
|
2200
|
|
FGF3 |
Approved |
fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) |
Hs.37092
|
NM_005247
|
NP_005238
|
Reviewed
|
2248
|
|
FLNA |
Approved |
filamin A, alpha (actin binding protein 280) |
Hs.58414 Hs.81008 Hs.195464
|
NM_001458 NM_001457 NM_001456
|
NP_001449 NP_001448 NP_001447
|
Reviewed Provisional Provisional
|
2316
|
|
FLNB |
Approved |
filamin B, beta (actin binding protein 278) |
Hs.58414 Hs.81008 Hs.195464
|
NM_001456 NM_001458 NM_001457
|
NP_001447 NP_001449 NP_001448
|
Provisional Reviewed Provisional
|
2317
|
|
FLNC |
Approved |
filamin C, gamma (actin binding protein 280) |
Hs.195464 Hs.58414 Hs.81008
|
NM_001458 NM_001456 NM_001457
|
NP_001449 NP_001447 NP_001448
|
Reviewed Provisional Provisional
|
2318
|
|
FLOT2 |
Approved |
flotillin 2 |
Hs.18799
|
NM_004475
|
NP_004466
|
Reviewed
|
2319
|
|
FN1 |
Approved |
fibronectin 1 |
Hs.418138
|
NM_002026 NM_054034
|
NP_002017 NP_473375
|
Reviewed Reviewed
|
2335
|
|
FUS |
Approved |
fusion (involved in t(12;16) in malignant liposarcoma) |
Hs.107720
|
NM_004960
|
NP_004951
|
Provisional
|
2521
|
|
FYN |
Approved |
FYN oncogene related to SRC, FGR, YES |
Hs.390567
|
NM_153047 NM_153048 NM_002037
|
NP_694592 NP_694593 NP_002028
|
Reviewed Reviewed Reviewed
|
2534
|
|
G22P1 |
Approved |
thyroid autoantigen 70kDa (Ku antigen) |
Hs.169744
|
NM_001469
|
NP_001460
|
Provisional
|
2547
|
|
GFAP |
Approved |
glial fibrillary acidic protein |
Hs.406397
|
NM_002055
|
NP_002046
|
Reviewed
|
2670
|
|
GGT1 |
Approved |
gamma-glutamyltransferase 1 |
Hs.289098 Hs.352119
|
NM_005265 NM_013421 XM_371427 NM_013430
|
NP_005256 NP_038265 XP_371427 NP_038347
|
Reviewed Reviewed Model, mRNA evidence Reviewed
|
2678
|
|
GGT2 |
Approved |
gamma-glutamyltransferase 2 |
Hs.352119 Hs.289098
|
NM_013430 NM_013421 XM_371427 NM_005265
|
NP_038347 NP_038265 XP_371427 NP_005256
|
Reviewed Reviewed Model, mRNA evidence Reviewed
|
2679
|
|
GH1 |
Approved |
growth hormone 1 |
Hs.500468 Hs.406754
|
NM_022558 NM_022560 NM_022557 NM_002059 NM_000515 NM_022556 NM_022562 NM_022559 NM_022561
|
NP_072052 NP_072054 NP_072051 NP_002050 NP_000506 NP_072050 NP_072056 NP_072053 NP_072055
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
2688
|
|
GH2 |
Approved |
growth hormone 2 |
Hs.406754 Hs.500468
|
NM_022562 NM_002059 NM_000515 NM_022561 NM_022559 NM_022557 NM_022560 NM_022556 NM_022558
|
NP_072056 NP_002050 NP_000506 NP_072055 NP_072053 NP_072051 NP_072054 NP_072050 NP_072052
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
2689
|
|
GJA1 |
Approved |
gap junction protein, alpha 1, 43kDa (connexin 43) |
Hs.74471
|
NM_000165
|
NP_000156
|
Reviewed
|
2697
|
|
GNAI1 |
Approved |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
Hs.203862
|
NM_002069
|
NP_002060
|
Validated
|
2770
|
|
GNAO1 |
Approved |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
Hs.241431
|
NM_138736 NM_020988
|
NP_620073 NP_066268
|
Provisional Provisional
|
2775
|
|
GNAT1 |
Approved |
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
Hs.51147
|
NM_000172 NM_144499
|
NP_000163 NP_653082
|
Reviewed Reviewed
|
2779
|
|
GNB2L1 |
Approved |
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
Hs.5662
|
NM_006098
|
NP_006089
|
Provisional
|
10399
|
|
GNRH1 |
Approved |
gonadotropin-releasing hormone 1 (leutinizing-releasing hormone) |
Hs.82963
|
NM_000825
|
NP_000816
|
Provisional
|
2796
|
|
GRB14 |
Approved |
growth factor receptor-bound protein 14 |
Hs.411881
|
NM_004490
|
NP_004481
|
Provisional
|
2888
|
|
GRB2 |
Approved |
growth factor receptor-bound protein 2 |
Hs.411366
|
NM_002086 NM_025199
|
NP_002077 NP_079475
|
Validated Secondary
|
2885
|
|
GSK3B |
Approved |
glycogen synthase kinase 3 beta |
Hs.282359
|
NM_002093
|
NP_002084
|
Provisional
|
2932
|
|
GSTP1 |
Approved |
glutathione S-transferase pi |
Hs.411509
|
NM_000852
|
NP_000843
|
Reviewed
|
2950
|
|
GTF2B |
Approved |
general transcription factor IIB |
Hs.258561
|
NM_001514
|
NP_001505
|
Reviewed
|
2959
|
|
GTF2I |
Approved |
general transcription factor II, i |
Hs.408507
|
NM_033003 NM_032999 NM_033001 NM_001518 NM_033000
|
NP_127496 NP_127492 NP_127494 NP_001509 NP_127493
|
Secondary Reviewed Reviewed Reviewed Reviewed
|
2969
|
|
HCLS1 |
Approved |
hematopoietic cell-specific Lyn substrate 1 |
Hs.14601
|
NM_005335
|
NP_005326
|
Provisional
|
3059
|
|
HIF1A |
Approved |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
Hs.412416
|
NM_001530 NM_181054
|
NP_001521 NP_851397
|
Reviewed Reviewed
|
3091
|
|
HMOX1 |
Approved |
heme oxygenase (decycling) 1 |
Hs.202833
|
NM_002133
|
NP_002124
|
Reviewed
|
3162
|
|
HMOX2 |
Approved |
heme oxygenase (decycling) 2 |
Hs.284279
|
NM_002134
|
NP_002125
|
Reviewed
|
3163
|
|
HRAS |
Approved |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
Hs.37003
|
NM_176795
|
NP_789765
|
Provisional
|
3265
|
|
HSPA4 |
Approved |
heat shock 70kDa protein 4 |
Hs.90093
|
NM_198431 NM_002154
|
NP_940833 NP_002145
|
Validated Validated
|
3308
|
|
HSPCA |
Approved |
heat shock 90kDa protein 1, alpha |
Hs.446579
|
NM_005348
|
NP_005339
|
Provisional
|
3320
|
|
HSPD1 |
Approved |
heat shock 60kDa protein 1 (chaperonin) |
Hs.79037
|
NM_002156 NM_199440
|
NP_002147 NP_955472
|
Reviewed Reviewed
|
3329
|
|
HSPH1 |
Approved |
heat shock 105kDa/110kDa protein 1 |
Hs.36927
|
NM_006644
|
NP_006635
|
Validated
|
10808
|
|
ICAM1 |
Approved |
intercellular adhesion molecule 1 (CD54), human rhinovirus receptor |
Hs.386467
|
NM_000201
|
NP_000192
|
Reviewed
|
3383
|
|
ICOSL |
Approved |
inducible T-cell co-stimulator ligand |
Hs.14155
|
NM_015259
|
NP_056074
|
Provisional
|
23308
|
|
IGFBP3 |
Approved |
insulin-like growth factor binding protein 3 |
Hs.450230
|
NM_000598
|
NP_000589
|
Provisional
|
3486
|
|
IKBKB |
Approved |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
Hs.413513
|
NM_001556 XM_032491
|
NP_001547 XP_032491
|
Validated Secondary
|
3551
|
|
IKBKG |
Approved |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
Hs.43505
|
NM_003639
|
NP_003630
|
Provisional
|
8517
|
|
ILF3 |
Approved |
interleukin enhancer binding factor 3, 90kDa |
Hs.256583
|
NM_012218 NM_004516 NM_153464
|
NP_036350 NP_004507 NP_703194
|
Reviewed Reviewed Reviewed
|
3609
|
|
ILK |
Approved |
integrin-linked kinase |
Hs.6196
|
NM_004517
|
NP_004508
|
Reviewed
|
3611
|
|
INSR |
Approved |
insulin receptor |
Hs.438669
|
NM_000208
|
NP_000199
|
Reviewed
|
3643
|
|
IRF1 |
Approved |
interferon regulatory factor 1 |
Hs.80645
|
NM_002198
|
NP_002189
|
Reviewed
|
3659
|
|
IRS1 |
Approved |
insulin receptor substrate 1 |
Hs.390242
|
NM_005544
|
NP_005535
|
Provisional
|
3667
|
|
ISGF3G |
Approved |
interferon-stimulated transcription factor 3, gamma 48kDa |
Hs.1706
|
NM_006084
|
NP_006075
|
Provisional
|
10379
|
|
ITGAV |
Approved |
integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) |
Hs.436873
|
NM_002210
|
NP_002201
|
Reviewed
|
3685
|
|
ITGB1 |
Approved |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
Hs.287797
|
NM_033667 NM_033669 NM_133376 NM_002211 NM_033666 NM_033668
|
NP_391987 NP_391989 NP_596867 NP_002202 NP_389647 NP_391988
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
3688
|
|
ITGB1BP2 |
Approved |
integrin beta 1 binding protein (melusin) 2 |
Hs.109999
|
NM_012278
|
NP_036410
|
Provisional
|
26548
|
|
JAK1 |
Approved |
Janus kinase 1 (a protein tyrosine kinase) |
Hs.436004
|
NM_002227
|
NP_002218
|
Reviewed
|
3716
|
|
JUN |
Approved |
v-jun sarcoma virus 17 oncogene homolog (avian) |
Hs.78465
|
NM_002228
|
NP_002219
|
Reviewed
|
3725
|
|
KAI1 |
Approved |
kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) |
Hs.323949
|
NM_002231
|
NP_002222
|
Reviewed
|
3732
|
|
KLK3 |
Approved |
kallikrein 3, (prostate specific antigen) |
Hs.171995
|
NM_145864 NM_001648
|
NP_665863 NP_001639
|
Reviewed Reviewed
|
354
|
|
KRT10 |
Approved |
keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris) |
Hs.99936
|
XM_352919 NM_000421
|
XP_352920 NP_000412
|
Secondary Reviewed
|
3858
|
|
KRT13 |
Approved |
keratin 13 |
Hs.433871
|
NM_153490 NM_002274
|
NP_705694 NP_002265
|
Reviewed Reviewed
|
3860
|
|
KRT14 |
Approved |
keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner) |
Hs.355214
|
NM_000526
|
NP_000517
|
Reviewed
|
3861
|
|
KRT15 |
Approved |
keratin 15 |
Hs.80342
|
NM_002275
|
NP_002266
|
Reviewed
|
3866
|
|
KRT16 |
Approved |
keratin 16 (focal non-epidermolytic palmoplantar keratoderma) |
Hs.432448
|
NM_005557
|
NP_005548
|
Reviewed
|
3868
|
|
KRT17 |
Approved |
keratin 17 |
Hs.2785
|
NM_000422
|
NP_000413
|
Reviewed
|
3872
|
|
KRT18 |
Approved |
keratin 18 |
Hs.406013
|
NM_000224 NM_199187
|
NP_000215 NP_954657
|
Reviewed Reviewed
|
3875
|
|
KRT19 |
Approved |
keratin 19 |
Hs.309517
|
NM_002276
|
NP_002267
|
Reviewed
|
3880
|
|
KRT20 |
Approved |
keratin 20 |
Hs.84905
|
NM_019010
|
NP_061883
|
Reviewed
|
54474
|
|
KRT4 |
Approved |
keratin 4 |
Hs.371139
|
NM_002272
|
NP_002263
|
Reviewed
|
3851
|
|
KRT6A |
Approved |
keratin 6A |
Hs.278658 Hs.446417 Hs.367762 Hs.432677 Hs.248189
|
NM_005555 NM_003771 NM_002284 NM_058242 NM_005554 NM_173086
|
NP_005546 NP_003762 NP_002275 NP_490596 NP_005545 NP_775109
|
Reviewed Reviewed Reviewed Reviewed Reviewed Provisional
|
3853
|
|
KRT6B |
Approved |
keratin 6B |
Hs.367762 Hs.446417 Hs.248189 Hs.278658 Hs.432677
|
NM_173086 NM_003771 NM_005555 NM_058242 NM_005554 NM_002284
|
NP_775109 NP_003762 NP_005546 NP_490596 NP_005545 NP_002275
|
Provisional Reviewed Reviewed Reviewed Reviewed Reviewed
|
3854
|
|
KRT6C |
Approved |
keratin 6C |
Hs.278658 Hs.432677 Hs.248189 Hs.446417 Hs.367762
|
NM_002284 NM_173086 NM_005554 NM_005555 NM_058242 NM_003771
|
NP_002275 NP_775109 NP_005545 NP_005546 NP_490596 NP_003762
|
Reviewed Provisional Reviewed Reviewed Reviewed Reviewed
|
140446
|
|
KRT6D |
Approved |
keratin 6D |
Hs.446417 Hs.367762 Hs.278658 Hs.432677 Hs.248189
|
NM_173086 NM_058242 NM_002284 NM_005555 NM_005554 NM_003771
|
NP_775109 NP_490596 NP_002275 NP_005546 NP_005545 NP_003762
|
Provisional Reviewed Reviewed Reviewed Reviewed Reviewed
|
140466
|
|
KRT6E |
Approved |
keratin 6E |
Hs.278658 Hs.432677 Hs.367762 Hs.248189 Hs.446417
|
NM_058242 NM_005555 NM_003771 NM_173086 NM_002284 NM_005554
|
NP_490596 NP_005546 NP_003762 NP_775109 NP_002275 NP_005545
|
Reviewed Reviewed Reviewed Provisional Reviewed Reviewed
|
286887
|
|
KRT7 |
Approved |
keratin 7 |
Hs.23881
|
NM_005556
|
NP_005547
|
Reviewed
|
3855
|
|
KRT8 |
Approved |
keratin 8 |
Hs.356123
|
NM_002273
|
NP_002264
|
Provisional
|
3856
|
|
KRTHA6 |
Approved |
keratin, hair, acidic, 6 |
Hs.432677 Hs.278658 Hs.367762 Hs.248189 Hs.446417
|
NM_005555 NM_005554 NM_002284 NM_173086 NM_058242 NM_003771
|
NP_005546 NP_005545 NP_002275 NP_775109 NP_490596 NP_003762
|
Reviewed Reviewed Reviewed Provisional Reviewed Reviewed
|
8689
|
|
KRTHB6 |
Approved |
keratin, hair, basic, 6 (monilethrix) |
Hs.446417 Hs.248189 Hs.367762 Hs.278658 Hs.432677
|
NM_173086 NM_005554 NM_058242 NM_003771 NM_005555 NM_002284
|
NP_775109 NP_005545 NP_490596 NP_003762 NP_005546 NP_002275
|
Provisional Reviewed Reviewed Reviewed Reviewed Reviewed
|
3892
|
|
LAIR1 |
Approved |
leukocyte-associated Ig-like receptor 1 |
Hs.407964
|
NM_021706 NM_002287 NM_021708
|
NP_068352 NP_002278 NP_068354
|
Reviewed Reviewed Reviewed
|
3903
|
|
LAT |
Approved |
linker for activation of T cells |
Hs.498997
|
NM_014387
|
NP_055202
|
Provisional
|
27040
|
|
LCK |
Approved |
lymphocyte-specific protein tyrosine kinase |
Hs.1765
|
NM_005356
|
NP_005347
|
Provisional
|
3932
|
|
LIG1 |
Approved |
ligase I, DNA, ATP-dependent |
Hs.1770
|
NM_000234
|
NP_000225
|
Reviewed
|
3978
|
|
LIG3 |
Approved |
ligase III, DNA, ATP-dependent |
Hs.100299
|
NM_002311 NM_013975
|
NP_002302 NP_039269
|
Reviewed Reviewed
|
3980
|
|
LYN |
Approved |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
Hs.80887
|
NM_002350
|
NP_002341
|
Provisional
|
4067
|
|
MADH2 |
Approved |
MAD, mothers against decapentaplegic homolog 2 (Drosophila) |
Hs.110741
|
NM_005901
|
NP_005892
|
Provisional
|
4087
|
|
MADH4 |
Approved |
MAD, mothers against decapentaplegic homolog 4 (Drosophila) |
Hs.75862
|
NM_005359
|
NP_005350
|
Provisional
|
4089
|
|
MAP2 |
Approved |
microtubule-associated protein 2 |
Hs.167
|
NM_002374 NM_031846 NM_031847 NM_031845
|
NP_002365 NP_114034 NP_114035 NP_114033
|
Reviewed Reviewed Reviewed Reviewed
|
4133
|
|
MAP2K1 |
Approved |
mitogen-activated protein kinase kinase 1 |
Hs.132311
|
NM_002755
|
NP_002746
|
Reviewed
|
5604
|
|
MAP2K2 |
Approved |
mitogen-activated protein kinase kinase 2 |
Hs.366546
|
NM_030662
|
NP_109587
|
Reviewed
|
5605
|
|
MAP2K3 |
Approved |
mitogen-activated protein kinase kinase 3 |
Hs.180533
|
NM_145110 NM_145109 NM_002756
|
NP_659732 NP_659731 NP_002747
|
Reviewed Reviewed Reviewed
|
5606
|
|
MAP2K5 |
Approved |
mitogen-activated protein kinase kinase 5 |
Hs.436145
|
NM_145160 NM_145162 NM_145161 NM_002757
|
NP_660143 NP_660145 NP_660144 NP_002748
|
Reviewed Reviewed Reviewed Reviewed
|
5607
|
|
MAP3K8 |
Approved |
mitogen-activated protein kinase kinase kinase 8 |
Hs.432453
|
NM_005204
|
NP_005195
|
Reviewed
|
1326
|
|
MAPK1 |
Approved |
mitogen-activated protein kinase 1 |
Hs.324473
|
NM_138957 NM_002745
|
NP_620407 NP_002736
|
Reviewed Reviewed
|
5594
|
|
MAPK12 |
Approved |
mitogen-activated protein kinase 12 |
Hs.432642
|
NM_002969
|
NP_002960
|
Reviewed
|
6300
|
|
MAPK13 |
Approved |
mitogen-activated protein kinase 13 |
Hs.178695
|
NM_002754
|
NP_002745
|
Reviewed
|
5603
|
|
MAPK14 |
Approved |
mitogen-activated protein kinase 14 |
Hs.79107
|
NM_139012 NM_001315 NM_139014 NM_139013
|
NP_620581 NP_001306 NP_620583 NP_620582
|
Reviewed Reviewed Reviewed Reviewed
|
1432
|
|
MAPK3 |
Approved |
mitogen-activated protein kinase 3 |
Hs.861
|
XM_055766 NM_002746
|
XP_055766 NP_002737
|
Secondary Provisional
|
5595
|
|
MAPK6 |
Approved |
mitogen-activated protein kinase 6 |
Hs.271980
|
NM_002748
|
NP_002739
|
Reviewed
|
5597
|
|
MAPK8 |
Approved |
mitogen-activated protein kinase 8 |
Hs.445864
|
NM_139047 NM_002750 NM_139046 NM_139049
|
NP_620635 NP_002741 NP_620634 NP_620637
|
Reviewed Reviewed Reviewed Reviewed
|
5599
|
|
MAPRE3 |
Approved |
microtubule-associated protein, RP/EB family, member 3 |
Hs.172740
|
NM_012326
|
NP_036458
|
Reviewed
|
22924
|
|
MAPT |
Approved |
microtubule-associated protein tau |
Hs.101174
|
NM_173727 NM_016834 NM_016841 NM_016835 NM_005910
|
NP_776088 NP_058518 NP_058525 NP_058519 NP_005901
|
Provisional Reviewed Reviewed Reviewed Reviewed
|
4137
|
|
MATK |
Approved |
megakaryocyte-associated tyrosine kinase |
Hs.437808
|
NM_139354 NM_002378 NM_139355
|
NP_647611 NP_002369 NP_647612
|
Reviewed Reviewed Reviewed
|
4145
|
|
MCAM |
Approved |
melanoma cell adhesion molecule |
Hs.511397
|
NM_006500
|
NP_006491
|
Provisional
|
4162
|
|
MCC |
Approved |
mutated in colorectal cancers |
Hs.409515
|
NM_002387
|
NP_002378
|
Reviewed
|
4163
|
|
MCL1 |
Approved |
myeloid cell leukemia sequence 1 (BCL2-related) |
Hs.86386
|
NM_021960 NM_182763
|
NP_068779 NP_877495
|
Reviewed Reviewed
|
4170
|
|
MCM2 |
Approved |
MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae) |
Hs.57101
|
NM_004526
|
NP_004517
|
Reviewed
|
4171
|
|
MCM7 |
Approved |
MCM7 minichromosome maintenance deficient 7 (S. cerevisiae) |
Hs.438720
|
NM_005916 NM_182776
|
NP_005907 NP_877577
|
Reviewed Reviewed
|
4176
|
|
MCP |
Approved |
membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen) |
Hs.83532
|
NM_172352 NM_172356 NM_153826 NM_172353 NM_172357 NM_002389 NM_172358 NM_172354 NM_172361 NM_172351 NM_172359 NM_172355 NM_172350 NM_172360
|
NP_758862 NP_758866 NP_722548 NP_758863 NP_758867 NP_002380 NP_758868 NP_758864 NP_758871 NP_758861 NP_758869 NP_758865 NP_758860 NP_758870
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
4179
|
|
MDM2 |
Approved |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) |
Hs.212217
|
NM_006881 NM_006879 NM_006878 NM_006882 NM_006880 NM_002392
|
NP_006872 NP_006870 NP_006869 NP_006873 NP_006871 NP_002383
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
4193
|
|
MET |
Approved |
met proto-oncogene (hepatocyte growth factor receptor) |
Hs.419124
|
NM_000245
|
NP_000236
|
Reviewed
|
4233
|
|
MGMT |
Approved |
O-6-methylguanine-DNA methyltransferase |
Hs.164140
|
NM_002412
|
NP_002403
|
Provisional
|
4255
|
|
MLANA |
Approved |
melan-A |
Hs.154069
|
NM_005511
|
NP_005502
|
Provisional
|
2315
|
|
MLH1 |
Approved |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
Hs.433618
|
NM_000249
|
NP_000240
|
Reviewed
|
4292
|
|
MLLT4 |
Approved |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
Hs.100469 Hs.280306
|
NM_005936
|
NP_005927
|
Provisional
|
4301
|
|
MMP1 |
Approved |
matrix metalloproteinase 1 (interstitial collagenase) |
Hs.83169
|
NM_002421
|
NP_002412
|
Reviewed
|
4312
|
|
MNAT1 |
Approved |
menage a trois 1 (CAK assembly factor) |
Hs.72870
|
NM_002431
|
NP_002422
|
Provisional
|
4331
|
|
MSH2 |
Approved |
mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
Hs.440394
|
NM_000251
|
NP_000242
|
Reviewed
|
4436
|
|
MSH6 |
Approved |
mutS homolog 6 (E. coli) |
Hs.445052
|
NM_000179
|
NP_000170
|
Provisional
|
2956
|
|
MSN |
Approved |
moesin |
Hs.170328
|
NM_002444
|
NP_002435
|
Reviewed
|
4478
|
|
MST1R |
Approved |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
Hs.2942
|
NM_002447
|
NP_002438
|
Provisional
|
4486
|
|
MUC2 |
Approved |
mucin 2, intestinal/tracheal |
Hs.315
|
NM_002457
|
NP_002448
|
Provisional
|
4583
|
|
MVP |
Approved |
major vault protein |
Hs.80680
|
NM_017458 NM_005115
|
NP_059447 NP_005106
|
Reviewed Reviewed
|
9961
|
|
MYC |
Approved |
v-myc myelocytomatosis viral oncogene homolog (avian) |
Hs.202453
|
NM_002467
|
NP_002458
|
Provisional
|
4609
|
|
MYOD1 |
Approved |
myogenic factor 3 |
Hs.181768
|
NM_002478
|
NP_002469
|
Reviewed
|
4654
|
|
MYOZ1 |
Approved |
myozenin 1 |
Hs.238756
|
NM_021245
|
NP_067068
|
Provisional
|
58529
|
|
NCAM1 |
Approved |
neural cell adhesion molecule 1 |
Hs.78792
|
NM_181351 NM_000615
|
NP_851996 NP_000606
|
Provisional Provisional
|
4684
|
|
NCK1 |
Approved |
NCK adaptor protein 1 |
Hs.54589
|
NM_006153
|
NP_006144
|
Reviewed
|
4690
|
|
NCOA2 |
Approved |
nuclear receptor coactivator 2 |
Hs.446678
|
NM_006540
|
NP_006531
|
Provisional
|
10499
|
|
NCOA3 |
Approved |
nuclear receptor coactivator 3 |
Hs.382168
|
NM_181659 NM_006534
|
NP_858045 NP_006525
|
Reviewed Reviewed
|
8202
|
|
NEFL |
Approved |
neurofilament, light polypeptide 68kDa |
Hs.107600
|
NM_006158
|
NP_006149
|
Provisional
|
4747
|
|
NFKBIA |
Approved |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
Hs.81328
|
NM_020529
|
NP_065390
|
Provisional
|
4792
|
|
NME1 |
Approved |
non-metastatic cells 1, protein (NM23A) expressed in |
Hs.118638
|
NM_000269 NM_198175
|
NP_000260 NP_937818
|
Reviewed Reviewed
|
4830
|
|
NR3C1 |
Approved |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
Hs.126608
|
NM_000176
|
NP_000167
|
Provisional
|
2908
|
|
NUDT5 |
Approved |
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
Hs.410205
|
NM_014142
|
NP_054861
|
Validated
|
11164
|
|
NUP214 |
Approved |
nucleoporin 214kDa |
Hs.460294
|
NM_005085 NM_153642
|
NP_005076 NP_705906
|
Reviewed Secondary
|
8021
|
|
OCLN |
Approved |
occludin |
Hs.171952
|
NM_002538
|
NP_002529
|
Reviewed
|
4950
|
|
OXA1L |
Approved |
oxidase (cytochrome c) assembly 1-like |
Hs.151134
|
NM_005015
|
NP_005006
|
Provisional
|
5018
|
|
PCNA |
Approved |
proliferating cell nuclear antigen |
Hs.78996
|
NM_002592 NM_182649
|
NP_002583 NP_872590
|
Reviewed Reviewed
|
5111
|
|
PDLIM1 |
Approved |
PDZ and LIM domain 1 (elfin) |
Hs.75807
|
NM_020992
|
NP_066272
|
Provisional
|
9124
|
|
PDPK1 |
Approved |
3-phosphoinositide dependent protein kinase-1 |
Hs.154729
|
NM_002613
|
NP_002604
|
Provisional
|
5170
|
|
PECI |
Approved |
peroxisomal D3,D2-enoyl-CoA isomerase |
Hs.15250
|
NM_006117
|
NP_006108
|
Provisional
|
10455
|
|
PGR |
Approved |
progesterone receptor |
Hs.2905
|
NM_000926
|
NP_000917
|
Provisional
|
5241
|
|
PICALM |
Approved |
phosphatidylinositol binding clathrin assembly protein |
Hs.39252
|
NM_007166
|
NP_009097
|
Provisional
|
8301
|
|
PIK3C2B |
Approved |
phosphoinositide-3-kinase, class 2, beta polypeptide |
Hs.343329
|
NM_002646
|
NP_002637
|
Reviewed
|
5287
|
|
PIK3R1 |
Approved |
phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) |
Hs.6241
|
NM_181504 NM_181524 NM_181523
|
NP_852556 NP_852665 NP_852664
|
Reviewed Reviewed Reviewed
|
5295
|
|
PITPN |
Approved |
phosphotidylinositol transfer protein |
Hs.433429
|
NM_006224
|
NP_006215
|
Provisional
|
5306
|
|
PNUTL1 |
Approved |
peanut-like 1 (Drosophila) |
Hs.258855 Hs.283743
|
NM_002688
|
NP_002679
|
Reviewed
|
5413
|
|
POLB |
Approved |
polymerase (DNA directed), beta |
Hs.180107
|
NM_002690
|
NP_002681
|
Provisional
|
5423
|
|
POLD1 |
Approved |
polymerase (DNA directed), delta 1, catalytic subunit 125kDa |
Hs.279413
|
NM_002691
|
NP_002682
|
Provisional
|
5424
|
|
POLE |
Approved |
polymerase (DNA directed), epsilon |
Hs.436458
|
NM_006231
|
NP_006222
|
Provisional
|
5426
|
|
PPP1R2 |
Approved |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
Hs.267819
|
NM_006241
|
NP_006232
|
Provisional
|
5504
|
|
PPP2CA |
Approved |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
Hs.91773
|
NM_002715
|
NP_002706
|
Provisional
|
5515
|
|
PPP2R5A |
Approved |
protein phosphatase 2, regulatory subunit B (B56), alpha isoform |
Hs.155079
|
NM_006243
|
NP_006234
|
Reviewed
|
5525
|
|
PPP3CA |
Approved |
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
Hs.272458
|
NM_000944
|
NP_000935
|
Provisional
|
5530
|
|
PPYR1 |
Approved |
pancreatic polypeptide receptor 1 |
Hs.524719
|
NM_005972
|
NP_005963
|
Provisional
|
5540
|
|
PRKAA2 |
Approved |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
Hs.256067
|
NM_006252
|
NP_006243
|
Provisional
|
5563
|
|
PRKACA |
Approved |
protein kinase, cAMP-dependent, catalytic, alpha |
Hs.194350
|
NM_002730
|
NP_002721
|
Provisional
|
5566
|
|
PRKAR1A |
Approved |
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) |
Hs.280342
|
NM_002734
|
NP_002725
|
Provisional
|
5573
|
|
PRKAR1B |
Approved |
protein kinase, cAMP-dependent, regulatory, type I, beta |
Hs.1519
|
NM_002735
|
NP_002726
|
Provisional
|
5575
|
|
PRKAR2A |
Approved |
protein kinase, cAMP-dependent, regulatory, type II, alpha |
Hs.440404
|
NM_004157
|
NP_004148
|
Provisional
|
5576
|
|
PRKAR2B |
Approved |
protein kinase, cAMP-dependent, regulatory, type II, beta |
Hs.77439
|
NM_002736
|
NP_002727
|
Provisional
|
5577
|
|
PRKCA |
Approved |
protein kinase C, alpha |
Hs.349611
|
NM_002737
|
NP_002728
|
Provisional
|
5578
|
|
PRKCB1 |
Approved |
protein kinase C, beta 1 |
Hs.349845
|
NM_002738
|
NP_002729
|
Provisional
|
5579
|
|
PRKCD |
Approved |
protein kinase C, delta |
Hs.155342
|
NM_006254
|
NP_006245
|
Provisional
|
5580
|
|
PRKCE |
Approved |
protein kinase C, epsilon |
Hs.155281
|
NM_005400
|
NP_005391
|
Provisional
|
5581
|
|
PRKCG |
Approved |
protein kinase C, gamma |
Hs.2890
|
NM_002739
|
NP_002730
|
Provisional
|
5582
|
|
PRKCH |
Approved |
protein kinase C, eta |
Hs.315366
|
NM_024064 NM_006255
|
NP_076969 NP_006246
|
Secondary Provisional
|
5583
|
|
PRKCI |
Approved |
protein kinase C, iota |
Hs.496511
|
NM_002740
|
NP_002731
|
Provisional
|
5584
|
|
PRKCQ |
Approved |
protein kinase C, theta |
Hs.408049
|
NM_006257
|
NP_006248
|
Provisional
|
5588
|
|
PRKDC |
Approved |
protein kinase, DNA-activated, catalytic polypeptide |
Hs.415749
|
NM_006904
|
NP_008835
|
Provisional
|
5591
|
|
PRPF18 |
Approved |
PRP18 pre-mRNA processing factor 18 homolog (yeast) |
Hs.306456
|
NM_003675
|
NP_003666
|
Reviewed
|
8559
|
|
PRSS8 |
Approved |
protease, serine, 8 (prostasin) |
Hs.75799
|
NM_002773
|
NP_002764
|
Reviewed
|
5652
|
|
PSME3 |
Approved |
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki) |
Hs.152978
|
NM_005789 NM_176863
|
NP_005780 NP_789839
|
Reviewed Reviewed
|
10197
|
|
PSMF1 |
Approved |
proteasome (prosome, macropain) inhibitor subunit 1 (PI31) |
Hs.437495
|
NM_178578 NM_006814 NM_178579
|
NP_848693 NP_006805 NP_848694
|
Reviewed Reviewed Reviewed
|
9491
|
|
PTEN |
Approved |
phosphatase and tensin homolog (mutated in multiple advanced cancers 1) |
Hs.253309
|
NM_000314
|
NP_000305
|
Reviewed
|
5728
|
|
PTGS2 |
Approved |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
Hs.196384
|
NM_000963
|
NP_000954
|
Reviewed
|
5743
|
|
PTK2 |
Approved |
PTK2 protein tyrosine kinase 2 |
Hs.434281
|
NM_005607 NM_153831
|
NP_005598 NP_722560
|
Reviewed Reviewed
|
5747
|
|
PTK2B |
Approved |
PTK2B protein tyrosine kinase 2 beta |
Hs.405474
|
NM_173176 NM_004103 NM_173175 NM_173174
|
NP_775268 NP_004094 NP_775267 NP_775266
|
Reviewed Reviewed Reviewed Reviewed
|
2185
|
|
PTPN11 |
Approved |
protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) |
Hs.83572
|
NM_032904 NM_002834
|
NP_116293 NP_002825
|
Secondary Reviewed
|
5781
|
|
PTPN6 |
Approved |
protein tyrosine phosphatase, non-receptor type 6 |
Hs.63489
|
NM_080549 NM_002831 NM_080548
|
NP_536859 NP_002822 NP_536858
|
Reviewed Reviewed Reviewed
|
5777
|
|
PTPRC |
Approved |
protein tyrosine phosphatase, receptor type, C |
Hs.444324
|
NM_080922 NM_080923 NM_002838 NM_080921
|
NP_563579 NP_563580 NP_002829 NP_563578
|
Reviewed Reviewed Reviewed Reviewed
|
5788
|
|
PXF |
Approved |
peroxisomal farnesylated protein |
Hs.441109
|
-
|
-
|
-
|
5824
|
|
PXN |
Approved |
paxillin |
Hs.446336
|
NM_002859
|
NP_002850
|
Provisional
|
5829
|
|
RAB11A |
Approved |
RAB11A, member RAS oncogene family |
Hs.75618
|
NM_004663
|
NP_004654
|
Reviewed
|
8766
|
|
RAB27A |
Approved |
RAB27A, member RAS oncogene family |
Hs.298530
|
NM_183234 NM_004580 NM_183235 NM_183236
|
NP_899057 NP_004571 NP_899058 NP_899059
|
Reviewed Reviewed Reviewed Reviewed
|
5873
|
|
RAB3A |
Approved |
RAB3A, member RAS oncogene family |
Hs.27744
|
NM_002866
|
NP_002857
|
Provisional
|
5864
|
|
RAB4A |
Approved |
RAB4A, member RAS oncogene family |
Hs.296169
|
NM_004578
|
NP_004569
|
Provisional
|
5867
|
|
RAB5A |
Approved |
RAB5A, member RAS oncogene family |
Hs.73957
|
NM_004162
|
NP_004153
|
Provisional
|
5868
|
|
RAB8A |
Approved |
RAB8A, member RAS oncogene family |
Hs.5947
|
NM_005370
|
NP_005361
|
Validated
|
4218
|
|
RABEP1 |
Approved |
rabaptin, RAB GTPase binding effector protein 1 |
Hs.390163 Hs.406335
|
NM_004703
|
NP_004694
|
Provisional
|
9135
|
|
RAC1 |
Approved |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
Hs.413812
|
NM_198829 NM_006908 NM_018890
|
NP_942126 NP_008839 NP_061485
|
Reviewed Reviewed Reviewed
|
5879
|
|
RAD23B |
Approved |
RAD23 homolog B (S. cerevisiae) |
Hs.159087
|
NM_002874
|
NP_002865
|
Reviewed
|
5887
|
|
RAD50 |
Approved |
RAD50 homolog (S. cerevisiae) |
Hs.41587
|
NM_005732 NM_133482
|
NP_005723 NP_597816
|
Reviewed Reviewed
|
10111
|
|
RALA |
Approved |
v-ral simian leukemia viral oncogene homolog A (ras related) |
Hs.6906
|
NM_005402
|
NP_005393
|
Reviewed
|
5898
|
|
RAN |
Approved |
RAN, member RAS oncogene family |
Hs.10842
|
NM_006325
|
NP_006316
|
Reviewed
|
5901
|
|
RAP2A |
Approved |
RAP2A, member of RAS oncogene family |
Hs.48554
|
NM_021033
|
NP_066361
|
Provisional
|
5911
|
|
RASA1 |
Approved |
RAS p21 protein activator (GTPase activating protein) 1 |
Hs.758
|
NM_002890 NM_022650
|
NP_002881 NP_072179
|
Reviewed Reviewed
|
5921
|
|
RB1 |
Approved |
retinoblastoma 1 (including osteosarcoma) |
Hs.408528
|
NM_000321
|
NP_000312
|
Reviewed
|
5925
|
|
RBBP4 |
Approved |
retinoblastoma binding protein 4 |
Hs.16003
|
NM_005610
|
NP_005601
|
Reviewed
|
5928
|
|
RBL2 |
Approved |
retinoblastoma-like 2 (p130) |
Hs.283604
|
NM_005611
|
NP_005602
|
Provisional
|
5934
|
|
RCOR |
Approved |
REST corepressor |
Hs.405373
|
NM_015156
|
NP_055971
|
Provisional
|
23186
|
|
RELA |
Approved |
v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) |
Hs.132594
|
NM_021975
|
NP_068810
|
Provisional
|
5970
|
|
RHO |
Approved |
rhodopsin (opsin 2, rod pigment) (retinitis pigmentosa 4, autosomal dominant) |
Hs.247565
|
NM_000539
|
NP_000530
|
Reviewed
|
6010
|
|
RIMS1 |
Approved |
regulating synaptic membrane exocytosis 1 |
Hs.509841
|
NM_014989
|
NP_055804
|
Provisional
|
22999
|
|
RIPK1 |
Approved |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
Hs.390758
|
NM_003804
|
NP_003795
|
Provisional
|
8737
|
|
RNASEH2A |
Approved |
ribonuclease H2, large subunit |
Hs.25292
|
NM_006397
|
NP_006388
|
Validated
|
10535
|
|
RPH3A |
Approved |
rabphilin 3A homolog (mouse) |
Hs.21239
|
-
|
-
|
-
|
22895
|
|
RPS6KA1 |
Approved |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
Hs.149957
|
NM_002953
|
NP_002944
|
Provisional
|
6195
|
|
RPS6KB1 |
Approved |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
Hs.86858
|
NM_003161
|
NP_003152
|
Provisional
|
6198
|
|
SCA2 |
Approved |
spinocerebellar ataxia 2 (olivopontocerebellar ataxia 2, autosomal dominant, ataxin 2) |
Hs.76253
|
NM_002973
|
NP_002964
|
Reviewed
|
6311
|
|
SCAMP1 |
Approved |
secretory carrier membrane protein 1 |
Hs.31218
|
NM_052822 NM_004866
|
NP_438173 NP_004857
|
Reviewed Reviewed
|
9522
|
|
SCARB1 |
Approved |
scavenger receptor class B, member 1 |
Hs.130981
|
NM_005505
|
NP_005496
|
Provisional
|
949
|
|
SCYE1 |
Approved |
small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) |
Hs.105656
|
NM_004757
|
NP_004748
|
Reviewed
|
9255
|
|
SEC8L1 |
Approved |
SEC8-like 1 (S. cerevisiae) |
Hs.446140
|
NM_021807
|
NP_068579
|
Reviewed
|
60412
|
|
SEMA4D |
Approved |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
Hs.511748
|
NM_006378
|
NP_006369
|
Provisional
|
10507
|
|
SERPINB13 |
Approved |
serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 13 |
Hs.241407
|
NM_012397
|
NP_036529
|
Provisional
|
5275
|
|
SFN |
Approved |
stratifin |
Hs.184510 Hs.523726
|
NM_006142
|
NP_006133
|
Provisional
|
2810
|
|
SHC1 |
Approved |
SHC (Src homology 2 domain containing) transforming protein 1 |
Hs.433795
|
NM_183001 NM_003029
|
NP_892113 NP_003020
|
Provisional Provisional
|
6464
|
|
SHC3 |
Approved |
src homology 2 domain containing transforming protein C3 |
Hs.151123
|
NM_016848
|
NP_058544
|
Provisional
|
53358
|
|
SILV |
Approved |
silver homolog (mouse) |
Hs.95972
|
NM_006928
|
NP_008859
|
Validated
|
6490
|
|
SIP1 |
Approved |
survival of motor neuron protein interacting protein 1 |
Hs.102456
|
NM_003616
|
NP_003607
|
Provisional
|
8487
|
|
SLC25A12 |
Approved |
solute carrier family 25 (mitochondrial carrier, Aralar), member 12 |
Hs.353282
|
NM_003705
|
NP_003696
|
Provisional
|
8604
|
|
SMARCA2 |
Approved |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
Hs.396404
|
NM_139045 NM_003070
|
NP_620614 NP_003061
|
Reviewed Reviewed
|
6595
|
|
SMARCB1 |
Approved |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
Hs.512700
|
NM_003073
|
NP_003064
|
Provisional
|
6598
|
|
SMARCD1 |
Approved |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
Hs.79335
|
NM_003076 NM_139071
|
NP_003067 NP_620710
|
Reviewed Reviewed
|
6602
|
|
SMN1 |
Approved |
survival of motor neuron 1, telomeric |
Hs.419469 Hs.458344 Hs.288986
|
NM_000344 NM_022874
|
NP_000335 NP_075012
|
Reviewed Reviewed
|
6606
|
|
SNAP25 |
Approved |
synaptosomal-associated protein, 25kDa |
Hs.221974
|
NM_130811 NM_003081
|
NP_570824 NP_003072
|
Reviewed Reviewed
|
6616
|
|
STAT1 |
Approved |
signal transducer and activator of transcription 1, 91kDa |
Hs.21486
|
NM_007315 NM_139266
|
NP_009330 NP_644671
|
Reviewed Reviewed
|
6772
|
|
STAT2 |
Approved |
signal transducer and activator of transcription 2, 113kDa |
Hs.72988
|
NM_005419
|
NP_005410
|
Reviewed
|
6773
|
|
STAT3 |
Approved |
signal transducer and activator of transcription 3 (acute-phase response factor) |
Hs.421342
|
NM_139276 NM_003150
|
NP_644805 NP_003141
|
Reviewed Reviewed
|
6774
|
|
STAT4 |
Approved |
signal transducer and activator of transcription 4 |
Hs.80642
|
NM_003151
|
NP_003142
|
Reviewed
|
6775
|
|
STAT5A |
Approved |
signal transducer and activator of transcription 5A |
Hs.437058
|
NM_003152
|
NP_003143
|
Reviewed
|
6776
|
|
STAT6 |
Approved |
signal transducer and activator of transcription 6, interleukin-4 induced |
Hs.437475
|
NM_003153
|
NP_003144
|
Reviewed
|
6778
|
|
STIM1 |
Approved |
stromal interaction molecule 1 |
Hs.74597
|
NM_003156
|
NP_003147
|
Reviewed
|
6786
|
|
STX11 |
Approved |
syntaxin 11 |
Hs.118958
|
NM_003764
|
NP_003755
|
Provisional
|
8676
|
|
STX4A |
Approved |
syntaxin 4A (placental) |
Hs.83734
|
NM_004604
|
NP_004595
|
Provisional
|
6810
|
|
STX6 |
Approved |
syntaxin 6 |
Hs.157144
|
NM_005819
|
NP_005810
|
Provisional
|
10228
|
|
STXBP1 |
Approved |
syntaxin binding protein 1 |
Hs.325862
|
NM_003165
|
NP_003156
|
Provisional
|
6812
|
|
SUPT5H |
Approved |
suppressor of Ty 5 homolog (S. cerevisiae) |
Hs.437056
|
NM_003169
|
NP_003160
|
Provisional
|
6829
|
|
SYN2 |
Approved |
synapsin II |
Hs.445503
|
NM_003178 NM_133625
|
NP_003169 NP_598328
|
Reviewed Reviewed
|
6854
|
|
SYNGR1 |
Approved |
synaptogyrin 1 |
Hs.414343
|
NM_004711 NM_145738 NM_145731
|
NP_004702 NP_663791 NP_663783
|
Reviewed Reviewed Reviewed
|
9145
|
|
SYP |
Approved |
synaptophysin |
Hs.75667
|
NM_003179
|
NP_003170
|
Provisional
|
6855
|
|
SYT5 |
Approved |
synaptotagmin V |
Hs.23179
|
NM_003180
|
NP_003171
|
Provisional
|
6861
|
|
TBP |
Approved |
TATA box binding protein |
Hs.1100
|
NM_003194
|
NP_003185
|
Reviewed
|
6908
|
|
TCEA1 |
Approved |
transcription elongation factor A (SII), 1 |
Hs.78869
|
NM_006756
|
NP_006747
|
Provisional
|
6917
|
|
TCERG1 |
Approved |
transcription elongation regulator 1 (CA150) |
Hs.300052
|
NM_006706
|
NP_006697
|
Reviewed
|
10915
|
|
TERF2IP |
Approved |
telomeric repeat binding factor 2, interacting protein |
Hs.274428
|
NM_018975
|
NP_061848
|
Provisional
|
54386
|
|
TFAP2A |
Approved |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
Hs.210911
|
NM_003220
|
NP_003211
|
Provisional
|
7020
|
|
TFDP1 |
Approved |
transcription factor Dp-1 |
Hs.79353
|
NM_007111
|
NP_009042
|
Provisional
|
7027
|
|
TGFB1I1 |
Approved |
transforming growth factor beta 1 induced transcript 1 |
Hs.25511
|
NM_015927
|
NP_057011
|
Provisional
|
7041
|
|
THBS1 |
Approved |
thrombospondin 1 |
Hs.164226
|
NM_003246
|
NP_003237
|
Reviewed
|
7057
|
|
TNFRSF5 |
Approved |
tumor necrosis factor receptor superfamily, member 5 |
Hs.504816
|
NM_001250 NM_152854
|
NP_001241 NP_690593
|
Reviewed Reviewed
|
958
|
|
TNFRSF6 |
Approved |
tumor necrosis factor receptor superfamily, member 6 |
Hs.82359
|
NM_152877 NM_152871 NM_152875 NM_152873 NM_000043 NM_152876 NM_152874 NM_152872
|
NP_690616 NP_690610 NP_690614 NP_690612 NP_000034 NP_690615 NP_690613 NP_690611
|
Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed Reviewed
|
355
|
|
TNFSF6 |
Approved |
tumor necrosis factor (ligand) superfamily, member 6 |
Hs.2007
|
NM_000639
|
NP_000630
|
Reviewed
|
356
|
|
TOP1 |
Approved |
topoisomerase (DNA) I |
Hs.253536
|
NM_003286
|
NP_003277
|
Reviewed
|
7150
|
|
TP53 |
Approved |
tumor protein p53 (Li-Fraumeni syndrome) |
Hs.408312
|
NM_000546
|
NP_000537
|
Reviewed
|
7157
|
|
TP53BP2 |
Approved |
tumor protein p53 binding protein, 2 |
Hs.44585
|
NM_005426
|
NP_005417
|
Provisional
|
7159
|
|
TP53I3 |
Approved |
tumor protein p53 inducible protein 3 |
Hs.50649
|
NM_147184 NM_004881
|
NP_671713 NP_004872
|
Reviewed Reviewed
|
9540
|
|
TP73 |
Approved |
tumor protein p73 |
Hs.192132
|
NM_005427
|
NP_005418
|
Provisional
|
7161
|
|
TP73L |
Approved |
tumor protein p73-like |
Hs.137569
|
NM_003722
|
NP_003713
|
Provisional
|
8626
|
|
TRADD |
Approved |
TNFRSF1A-associated via death domain |
-
|
NM_153425 NM_003789
|
NP_700474 NP_003780
|
Reviewed Reviewed
|
8717
|
|
TRAF4 |
Approved |
TNF receptor-associated factor 4 |
Hs.8375
|
NM_145751 NM_004295
|
NP_665694 NP_004286
|
Reviewed Reviewed
|
9618
|
|
TSNAX |
Approved |
translin-associated factor X |
Hs.96247
|
NM_005999
|
NP_005990
|
Reviewed
|
7257
|
|
TUBA1 |
Approved |
tubulin, alpha 1 (testis specific) |
Hs.406578 Hs.75318 Hs.349695 Hs.512712 Hs.433394 Hs.110837 Hs.303023 Hs.511743 Hs.287610 Hs.274398 Hs.446692 Hs.351544 Hs.433615 Hs.137400
|
NM_006088 NM_018943 NM_030773 NM_006001 NM_006087 NM_006009 NM_032704 NM_006086 NM_006000 NM_025019 NM_032525 NM_020040 NM_177987 NM_079836 NM_001069
|
NP_006079 NP_061816 NP_110400 NP_005992 NP_006078 NP_006000 NP_116093 NP_006077 NP_005991 NP_079295 NP_115914 NP_064424 NP_817124 NP_524575 NP_001060
|
Provisional Provisional Validated Reviewed Provisional Reviewed Provisional Provisional Reviewed Provisional Provisional Provisional Provisional Reviewed Provisional
|
7277
|
|
TUBA2 |
Approved |
tubulin, alpha 2 |
Hs.137400 Hs.406578 Hs.349695 Hs.511743 Hs.287610 Hs.274398 Hs.446692 Hs.351544 Hs.433615 Hs.512712 Hs.110837 Hs.433394 Hs.303023 Hs.75318
|
NM_006086 NM_006001 NM_079836 NM_032704 NM_020040 NM_032525 NM_177987 NM_025019 NM_006000 NM_006088 NM_001069 NM_006009 NM_006087 NM_030773 NM_018943
|
NP_006077 NP_005992 NP_524575 NP_116093 NP_064424 NP_115914 NP_817124 NP_079295 NP_005991 NP_006079 NP_001060 NP_006000 NP_006078 NP_110400 NP_061816
|
Provisional Reviewed Reviewed Provisional Provisional Provisional Provisional Provisional Reviewed Provisional Provisional Reviewed Provisional Validated Provisional
|
7278
|
|
TUBA4 |
Approved |
tubulin, alpha 4 |
Hs.351544 Hs.446692 Hs.406578 Hs.511743 Hs.287610 Hs.349695 Hs.137400 Hs.433615 Hs.433394 Hs.512712 Hs.303023 Hs.274398 Hs.110837 Hs.75318
|
NM_006001 NM_032525 NM_177987 NM_032704 NM_079836 NM_006087 NM_018943 NM_030773 NM_025019 NM_006000 NM_020040 NM_001069 NM_006088 NM_006009 NM_006086
|
NP_005992 NP_115914 NP_817124 NP_116093 NP_524575 NP_006078 NP_061816 NP_110400 NP_079295 NP_005991 NP_064424 NP_001060 NP_006079 NP_006000 NP_006077
|
Reviewed Provisional Provisional Provisional Reviewed Provisional Provisional Validated Provisional Reviewed Provisional Provisional Provisional Reviewed Provisional
|
80086
|
|
TUBA8 |
Approved |
tubulin, alpha 8 |
Hs.446692 Hs.287610 Hs.511743 Hs.351544 Hs.433615 Hs.137400 Hs.433394 Hs.349695 Hs.75318 Hs.274398 Hs.512712 Hs.110837 Hs.303023 Hs.406578
|
NM_006000 NM_025019 NM_006087 NM_079836 NM_020040 NM_177987 NM_032525 NM_001069 NM_006088 NM_030773 NM_006009 NM_018943 NM_006001 NM_006086 NM_032704
|
NP_005991 NP_079295 NP_006078 NP_524575 NP_064424 NP_817124 NP_115914 NP_001060 NP_006079 NP_110400 NP_006000 NP_061816 NP_005992 NP_006077 NP_116093
|
Reviewed Provisional Provisional Reviewed Provisional Provisional Provisional Provisional Provisional Validated Reviewed Provisional Reviewed Provisional Provisional
|
51807
|
|
TUBB |
Approved |
tubulin, beta polypeptide |
Hs.433615 Hs.110837 Hs.512712 Hs.303023 Hs.446692 Hs.274398 Hs.75318 Hs.351544 Hs.433394 Hs.137400 Hs.406578 Hs.349695 Hs.287610 Hs.511743
|
NM_032704 NM_020040 NM_032525 NM_006088 NM_006000 NM_006087 NM_025019 NM_001069 NM_006009 NM_018943 NM_030773 NM_079836 NM_006001 NM_006086 NM_177987
|
NP_116093 NP_064424 NP_115914 NP_006079 NP_005991 NP_006078 NP_079295 NP_001060 NP_006000 NP_061816 NP_110400 NP_524575 NP_005992 NP_006077 NP_817124
|
Provisional Provisional Provisional Provisional Reviewed Provisional Provisional Provisional Reviewed Provisional Validated Reviewed Reviewed Provisional Provisional
|
7280
|
|
TUBB1 |
Approved |
tubulin, beta 1 |
Hs.137400 Hs.406578 Hs.287610 Hs.512712 Hs.303023 Hs.274398 Hs.511743 Hs.75318 Hs.349695 Hs.446692 Hs.110837 Hs.433615 Hs.433394 Hs.351544
|
NM_079836 NM_018943 NM_030773 NM_006086 NM_006009 NM_177987 NM_032704 NM_025019 NM_020040 NM_006000 NM_006087 NM_032525 NM_006001 NM_001069 NM_006088
|
NP_524575 NP_061816 NP_110400 NP_006077 NP_006000 NP_817124 NP_116093 NP_079295 NP_064424 NP_005991 NP_006078 NP_115914 NP_005992 NP_001060 NP_006079
|
Reviewed Provisional Validated Provisional Reviewed Provisional Provisional Provisional Provisional Reviewed Provisional Provisional Reviewed Provisional Provisional
|
81027
|
|
TUBB4Q |
Approved |
tubulin, beta polypeptide 4, member Q |
Hs.349695 Hs.433394 Hs.274398 Hs.75318 Hs.303023 Hs.512712 Hs.110837 Hs.406578 Hs.351544 Hs.287610 Hs.137400 Hs.511743 Hs.446692 Hs.433615
|
NM_006009 NM_001069 NM_006088 NM_018943 NM_030773 NM_032704 NM_006086 NM_006001 NM_006087 NM_177987 NM_079836 NM_020040 NM_025019 NM_006000 NM_032525
|
NP_006000 NP_001060 NP_006079 NP_061816 NP_110400 NP_116093 NP_006077 NP_005992 NP_006078 NP_817124 NP_524575 NP_064424 NP_079295 NP_005991 NP_115914
|
Reviewed Provisional Provisional Provisional Validated Provisional Provisional Reviewed Provisional Provisional Reviewed Provisional Provisional Reviewed Provisional
|
56604
|
|
TYK2 |
Approved |
tyrosine kinase 2 |
Hs.75516
|
NM_003331
|
NP_003322
|
Provisional
|
7297
|
|
TYMS |
Approved |
thymidylate synthetase |
Hs.87491
|
NM_001071
|
NP_001062
|
Provisional
|
7298
|
|
TYR |
Approved |
tyrosinase (oculocutaneous albinism IA) |
Hs.2053
|
NM_000372
|
NP_000363
|
Provisional
|
7299
|
|
UFD1L |
Approved |
ubiquitin fusion degradation 1-like |
Hs.404525
|
NM_005659
|
NP_005650
|
Provisional
|
7353
|
|
UNC13B |
Approved |
unc-13 homolog B (C. elegans) |
Hs.155001
|
NM_006377
|
NP_006368
|
Reviewed
|
10497
|
|
VASP |
Approved |
vasodilator-stimulated phosphoprotein |
Hs.403914
|
NM_003370
|
NP_003361
|
Provisional
|
7408
|
|
VEGF |
Approved |
vascular endothelial growth factor |
Hs.73793
|
NM_003376
|
NP_003367
|
Provisional
|
7422
|
|
VHL |
Approved |
von Hippel-Lindau syndrome |
Hs.421597
|
NM_000551 NM_198156
|
NP_000542 NP_937799
|
Reviewed Reviewed
|
7428
|
|
VIL1 |
Approved |
villin 1 |
Hs.512713
|
NM_007127
|
NP_009058
|
Reviewed
|
7429
|
|
VIL2 |
Approved |
villin 2 (ezrin) |
Hs.403997
|
NM_003379
|
NP_003370
|
Reviewed
|
7430
|
|
VIM |
Approved |
vimentin |
Hs.435800
|
NM_003380
|
NP_003371
|
Provisional
|
7431
|
|
WRN |
Approved |
Werner syndrome |
Hs.512715
|
NM_000553
|
NP_000544
|
Reviewed
|
7486
|
|
WT1 |
Approved |
Wilms tumor 1 |
Hs.1145
|
NM_024425 NM_024424 NM_024426 NM_000378
|
NP_077743 NP_077742 NP_077744 NP_000369
|
Reviewed Reviewed Reviewed Reviewed
|
7490
|
|
XPO1 |
Approved |
exportin 1 (CRM1 homolog, yeast) |
Hs.157367
|
NM_003400
|
NP_003391
|
Reviewed
|
7514
|
|
YWHAE |
Approved |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
Hs.79474
|
NM_006761
|
NP_006752
|
Reviewed
|
7531
|
|
YWHAG |
Approved |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
Hs.25001
|
NM_012479
|
NP_036611
|
Reviewed
|
7532
|